A US-based multinational biopharmaceutical company sought to leverage Generative AI for creating Informed Consent Forms (ICF) and Plain Language Protocol Synopses (PLPS) to streamline clinical trial documentation. Indegene's advanced GenAI software automated document preparation, achieving 50% effort reduction and 30% throughput increase while maintaining compliance. This intelligent platform accelerated production, minimized manual work, and enabled strategic focus on innovation, transforming complex regulatory document creation into an efficient, scalable process for faster trial advancement.

Join for free to read